Allakos INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

17 Apr 2025

ALLK

10-K/A: Allakos Inc. Files Amendment to 10-K Report to Include Omitted Information on Directors, Executive Compensation, and Governance

Allakos Inc. filed an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.

12 Mar 2025

ALLK

Allakos INC

10-K: Allakos Inc. Announces Strategic Review After Disappointing Trial Results, Plans Significant Restructuring

Allakos Inc. initiates a strategic review and implements a corporate restructuring following the failure of its AK006 clinical trial, leading to a 75% workforce reduction and discontinuation of AK006 development.

14 Mar 2024

ALLK

Allakos INC

10-K: Allakos Inc. Files 10-K, Provides Update on AK006 Development and Strategic Reorganization

Allakos Inc.'s 10-K filing details the company's focus on AK006, a strategic reorganization, and financial results for the year ended December 31, 2023.